Endocrine Abstracts

61-year-old-male with a background of treated hypertension and dyslipidaemia presented to accident and emergency with progressive shortness of breath. His most recent bloods were within normal limits. He has a positive family history of cardiac disease, and underwent investigation by CT scanning. This revealed a 10.2 mm anterior mediastinal nodule, which was not avid on PET CT scan. His case was reviewed by the respiratory team and he underwent a left VATs thymectomy. Thymic t...

59-year-old male, with a background of treated acromegaly, presented to endocrine clinic with new onset fatigue. He was diagnosed with acromegally 18 years prior to his presentation, and had a transphenoidal hypophysectomy followed by gamma-knife radiation. Post-surgery he developed partial anterior hypopituatrism (LH and FSH). He currently takes testosterone replacement. He is still receiving medical management with Somatuline. He developed hypothyroidism 16 years following h...

We report a case of a 57-year-old woman with profound uncontrolled hypothyroidism diagnosed in 1999. At her first Endocrine clinic visit in 2015, her TSH level was 93.4 mU/l with FT4 level of 4.8 pmo/l. Despite increasing her Levothyroxine dose, her TSH level remained persistently above 80 mU/l with a low FT4. She had a gastroscopy and coeliac screening which were non-significant. Triiodothyronine 10 mg was added to Levothyroxine 100 mg once daily in October 2015. However, she...

Dopamine agonists can falsely elevate plasma and urinary metanephrines, thus making the diagnosis of pheochromocytomas in patients taking these medications challenging. We present the case of an 80-year-old female care home resident with a background of hypertension, Parkinson’s disease (PD), dementia and pernicious anaemia. She presented with weight loss, unilateral leg swelling and abdominal distension. A computed tomography (CT) showed a 5.6 cm heterogeneously enhancin...

Alemtuzumab is a monoclonal antibody used in the treatment of relapsing-remitting multiple sclerosis (RRMS). Thyroid dysfunction is a common side effect. Alemtuzumab induced Graves’ disease (AIGD) is notable for its fluctuating and unpredictable course. We present the case of two women with RRMS who required total thyroidectomy to manage AIGD and were followed up in our antenatal endocrine clinic during their pregnancy. The first patient is a 31-year-old lady who develope...